The global rabies diagnostics market size is estimated to expand at a significant CAGR during the forecast period, 2021-2028. The growth of the market is attributed to innovative diagnostic tool for viral infection identification, increasing government initiatives for prevention and eradication of disease, and rising incidence rate of rabies in dense population and low resource regions. Moreover, the increasing research activities for development innovative diagnostics devices related to rabies and rising healthcare expenditure from governments are other key aspects for the market growth.
Request Free Sample Report Here
Rabies diagnosis is a medical procedure by which pathologist identify the presence of rabies virus either in human or in rabid animal. Direct fluorescent antibody test is most common employed method for diagnosis of rabies in infected animals by detection of antigen exist in brain. Reverse immunohistochemistry test, reverse transcriptase-polymerase chain reaction (RT-PCR), cell culture, intra-vitam process, nucleic acid detection, rapid fluorescent inhibition test, and enzyme linked immunosorbent assays (ELISA) are the most common methods by which medical professionals detect presence of rabies virus in human brain tissue. According to World Health Organization (WHO), 98% of rabies is caused by dog bite, 40% of people including approximately 60,000 deaths every year is related to rabies across the globe.
Market Trends, Drivers, Restraints, and Opportunities
- Innovation in diverse diagnostic tools that used for characterization of viral infection along with concluding validation of rabies disease acts as a key driver for the market growth.
- Introduction of efficient disease regulation programs from government agencies and providing support to elucidate awareness programs for prevention and control of disease are expected to propel the market expansion in the coming years.
- Rising incidence of rabies in dense populace and low medical facilities area in which this disease is progressively causing death in human and animal. This is another key driver for the market growth.
- Various global healthcare providers are actively involved in demonstrating research collaboration with biotech firms for the development of advanced diagnostic assays which are contributing to fuel the market growth during the forecast period.
- At present, laboratories use traditional chemical stain procedure as a diagnostic tool that provide less precise results along with the lack of infrastructure in low-resource areas are the key restraints projected to hinder the market growth in the upcoming years. High price of postexposure prophylaxis (PEP) is another key challenge for the market growth.
Global Rabies Diagnostics Market Segment Insights
Fluorescent antibody test segment is expected to grow at a rapid pace
Based on diagnostic methods, the global rabies diagnostics market is divided into fluorescent antibody test (FAT), immunohistochemical test, amplification methods, histological examination, and serology tests. The fluorescent antibody test segment is expected to account for a key share of the market in terms of revenue generation in the coming years due to broad usage and endorsed by WHO for diagnosis. Fluorescent antibody test offers precise results than other traditional approaches contributed to wide utilization of this test, which further propels the segment growth.
ELISA/Immunohistochemistry segment is projected to account for a key market share
On the basis of technology, the market is classified into ELISA/immunohistochemistry, chromatography techniques, PCR, and others. The ELISA/immunohistochemistry segment is anticipated to register a robust CAGR during the forecast period due to large perforation of assays. Different diagnostic tests based of ELISA are fluorescent antibody test (FAT), rapid rabies enzyme immunodiagnosis (RREID), direct rapid immunohistochemical test (dRIT), rapid immunodiagnostic test (RIDT), and indirect rapid immunohistochemistry test (IRIT) offer precise results.
Compititive Landscape
Some of the key players performing in the market are Bio-Rad Laboratories, Inc.; Aviva Systems Biology Corporation; Merck KGaA; Demeditec Diagnostics GmbH; Creative Diagnostics; Norgen Biotek Corp.; Express Biotech International, Inc.; BIONOTE Co., LTD.; F. Hoffmann-La Roche Ltd.; Agilent Technologies Inc.; Thermo Fisher Scientific, and Qiagen. Many of these key players are actively investing in research & development to develop novel biopsy procedures to attain business augmentation that can further contribute to the market growth. Several of these companies are actively engaged in various market strategies such as product launches, mergers, partnerships, acquisitions, and expansion of production units to enhance their market position and expand their consumer base globally.
About Growth Market Reports:
GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GROWTH MARKET REPORTS has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.
Contact:
Growth Market Reports
Phone: +1 909 414 1393
Email: [email protected]
Web: https://growthmarketreports.com
Rabies Diagnostics Market Size, Trends and Outlook by Method (Fluorescent Antibody Test (FAT), Serology Tests, and Others), by Technology (ELISA/Immunohistochemistry, and Others), by End User (Hospitals Diagnostic centers, others) - Global Forecast till 2027Overview:The global report, with substantial studies of the rabies diagnosis market, reveals that the market is showing signs of expansion with 4.36% CAGR during the forecast period (2018-2023).
Rabies is a virus often found in animals, and if they bite humans, they transmit the virus to the human body.
Various non-profit organizations are also taking proper steps using collaboration as an effective measure to inspire market growth.However, the rabies diagnosis market may find its growth hampered by the rising number of vaccination as a preventive measure and high cost that comes with the diagnostic procedure.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7796 Segmentation:MRFR’s take on the global rabies diagnosis market can be segmented into several segments like method, technology, and end user.
These segments reveal inputs and insights that can be later used for a better understanding of the market and devising strategies.By method, the global report on the rabies diagnosis market can be segmented into an immunohistochemical test, histologic examination, amplification methods, fluorescent antibody test (FAT), and serology tests.By technology, the global report on the rabies diagnosis market can be segmented into chromatography techniques, PCR, ELISA/immunohistochemistry, and others.
The ELISA/immunohistochemistry is quite popular among physicians who look for such changes.By end user, the report on the rabies diagnosis would encompass hospitals, diagnostic centers, cancer palliative care clinics, and others.
Improving the healthcare sector is expected to boost regional growth and ensure the sector gets proper funding.
